ClinicalTrials.gg
Sign In

Hemiplegia clinical trials

The registry lists 446 studies for Hemiplegia across more than 10 countries. 90 are recruiting or about to start. 178 of them are mainly about Hemiplegia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Hemiplegia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
256
Recruiting
57
Status unknown
51
Not yet recruiting
30
Terminated
25
Active, not recruiting
16

Phase

Phase 2
19
Phase 1
11
Phase 3
9
Phase 4
6
Early Phase 1
4

Where

Turkey
107
United States
94
France
32
Egypt
29
Pakistan
23
Korea, Republic of
18

Who runs them

Cairo University (15) · MetroHealth Medical Center (11) · Riphah International University (10) · Istanbul Physical Medicine Rehabilitation Training and Research Hospital (9) · Afyonkarahisar Health Sciences University (8) · University of Lahore (8) · Istinye University (6) · US Department of Veterans Affairs (6)

What is being tested here

Drugs under test in Hemiplegia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cerebrolysin101
Psilocybin101
Botulinum Toxins101
Botulinum toxin type A006
Lidocaine003
rimabotulinumtoxinB022
Meopa011
Onabotulinum toxin A001
Baclofen001
Triamcinolone001

Drug classes tested here Local anesthetics 4

Coming up

0phase 3 studies under way
25studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 57 Hemiplegia studies recruiting now, 16 (28%) set no upper age limit and 29 (51%) stop at 75 or younger. 8 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (12%) take healthy volunteers.

Recruiting studies that take each age, of 57
AgeWomenMen
107 (12%)7 (12%)
1833 (58%)33 (58%)
3037 (65%)37 (65%)
4041 (72%)41 (72%)
5048 (84%)48 (84%)
6547 (82%)47 (82%)
7534 (60%)34 (60%)
8521 (37%)21 (37%)

Across all 446 studies, recruiting or not: 47% stop at 75 or younger and 34% at 65; 24% take children; <1% are for women only and <1% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hemiplegia studies take

Of 228 interventional studies with no phase under Hemiplegia, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo5–27 · 228 studies—12 mo5–27 · 223 studies
Observational18 mo8–37 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 446. Browse all 446 → or search them.